Skip to main content
. 2020 Jan 14;10:223. doi: 10.1038/s41598-019-57080-9

Table 1.

Selected genes with high/moderate and low or unknown cancer predisposition in alphabetical order, autosomal dominant first, followed by autosomal recessive and X-linked transmission.

Gene name Location hg19 Gene MIM no. Tumour Types(Germline) Cancer Syndrome Inheri-tance ACMG recomm.
High risk genes with established predictions with surveillance recommendations
APC 5q22.2 611731 colorectal, pancreatic, desmoid, hepatoblastoma, glioma, other CNS adenomatous polyposis coli; Turcot syndrome AD yes
BMPR1A 10q23.2 601299 gastrointestinal polyps juvenile polyposis AD yes
BRCA1 17q21.31 113705 breast, ovarian hereditary breast/ovarian cancer AD yes
BRCA2 13q13.1 600185 breast, ovarian, pancreatic, leukaemia hereditary breast/ovarian cancer AD yes
CDH1 16q22.1 192090 gastric familial gastric carcinoma AD no
CDK4 12q14.1 123829 melanoma familial malignant melanoma AD no
CDKN2A 9p21.3 600160 melanoma, pancreatic familial malignant melanoma AD no
EPCAM 2p21 185535 colorectal Colorectal cancer, hereditary nonpolyposis, type 8 AD no
FH 1q43 136850 leiomyomatosis, renal hereditary leiomyomatosis and renal cell cancer AD no
FLCN 17p11.2 607273 renal, fibrofolliculomas, trichodiscomas Birt-Hogg-Dube syndrome AD no
MEN1 11q13.1 613733 parathyroid adenoma, pituitary adenoma, pancreatic islet cell, carcinoid multiple endocrine neoplasia type 1 AD yes
MLH1 3p22.2 120436 colorectal, endometrial, ovarian, central nervous system hereditary non-polyposis colorectal cancer, Turcot syndrome AD yes
MSH2 2p21-p16 609309 colorectal, endometrial, ovarian hereditary non-polyposis colorectal cancer AD yes
MSH6 2p16.3 600678 colorectal, endometrial, ovarian hereditary non-polyposis colorectal cancer AD yes
MUTYH 1p34.1 604933 colorectal adenomatous polyposis coli AR yes
NF1 17q11.2 613113 neurofibroma, glioma neurofibromatosis type 1 AD no
NF2 22q12.2 607379 meningioma, acoustic neuroma neurofibromatosis type 2 AD yes
PMS2 7p22.1 600259 colorectal, endometrial, ovarian, medulloblastoma, glioma hereditary non-polyposis colorectal cancer, Turcot syndrome AD yes
PTCH1 1p34.1 603673 skin basal cell, medulloblastoma nevoid basal cell carcinoma syndrome AD no
PTEN 10q23.31 601728 harmartoma, glioma, prostate, endometrial Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome AD yes
RB1 13q14.2 614041 retinoblastoma, sarcoma, breast, small cell lung carcinoma familial retinoblastoma AD yes
RET 10q11.21 164761 medullary thyroid, papillary thyroid, pheochromocytoma multiple endocrine neoplasia 2A/2B AD yes
SDHB 1p36.13 185470 paraganglioma, pheochromocytoma familial paraganglioma AD yes
SDHD 11q23.1 602690 paraganglioma, pheochromocytoma familial paraganglioma AD yes
SDHAF2 11q12.2 613019 paraganglioma familial paraganglioma AD yes
SDHC 1q23.3 602413 paraganglioma, pheochromocytoma familial paraganglioma AD yes
SMAD4 18q21.2 600993 gastrointestinal polyp juvenile polyposis AD yes
STK11 19p13.3 602216 jejunal hamartoma, ovarian, testicular, pancreatic Peutz-Jeghers syndrome AD yes
TGFBR2 3p24.1 190182 colorectal Hereditary Nonpolyposis Colorectal Cancer type 6 AD yes
TP53 17p13.1 191170 breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types Li-Fraumeni syndrome AD yes
TSC1 9q34.13 605284 hamartoma, renal cell carcinoma, tuberous sclerosis tuber Tuberous sclerosis 1 AD yes
TSC2 16p13.3 191092 hamartoma, renal cell carcinoma, tuberous sclerosis tuber Tuberous sclerosis 2 AD yes
VHL 3p25.3 608537 renal, haemangioma, pheochromocytoma Von Hippel-Lindau syndrome AD yes
WT1 11p13 607102 Wilms tumour Denys-Drash syndrome, Frasier syndrome, familial Wilms tumour AD yes
FANCA 16q24.3 607139 Acute myeloid leukemia, leukaemia Fanconi anaemia complementation group A AR no
FANCB Xp22.2 300515 Acute myeloid leukemia, leukaemia Fanconi anemia, complementation group B XLR no
FANCC 9q22.32 613899 Acute myeloid leukemia, leukaemia Fanconi anaemia complementation group C AR no
FANCD2 3p25.3 613984 Acute myeloid leukemia, leukaemia Fanconi anaemia complementation group D2 AR no
FANCE 6p21.31 613976 Acute myeloid leukemia, leukaemia Fanconi anaemia complementation group E AR no
FANCF 11p14.3 613897 Acute myeloid leukemia, leukaemia Fanconi anaemia complementation group F AR no
FANCG 9p13.3 602956 Acute myeloid leukemia, leukaemia Fanconi anaemia complementation group G AR no
FANCL 2p16.1 608111 Acute myeloid leukemia, leukaemia Fanconi anemia, complementation group L AR no
EGFR 7p11.2 131550 Non-small-cell lung carcinoma familial lung cancer AR no
ERCC2 19q13.32 126340 skin basal cell, skin squamous cell, melanoma Xeroderma pigmentosum, group D AR no
ERCC3 2q14.3 133510 skin basal cell, skin squamous cell, melanoma Xeroderma pigmentosum, group B AR no
ERCC4 16p13.12 133520 skin basal cell, skin squamous cell, melanoma Xeroderma pigmentosum, group F AR no
ERCC5 13q33.1 133530 skin basal cell, skin squamous cell, melanoma Xeroderma pigmentosum, group G AR no
EXT1 8q24.11 608177 exostoses, osteosarcoma multiple exostoses type 1 AR no
NBN 8q21.3 602667 Non-Hodgkin lymphoma, glioma, medulloblastoma, rhabdomyosarcoma Nijmegen breakage syndrome AR no
Moderate/increased risk genes that are acknowledged guidelines screening and risk reduction measures in accordance with family history
ALK 2p23.2-p23.1 105590 neuroblastoma familial neuroblastoma AD no
ATM 11q22.3 607585 leukaemia, lymphoma, medulloblastoma, glioma ataxia-telangiectasia AD no
BAP1 3p21.1 603089 mesothelioma, uveal melanoma Tumor predisposition syndrome AD no
BRIP1 17q23.2 605882 AML, leukaemia, breast Fanconi anaemia J, breast cancer susceptiblity AD no
CHEK2 22q12.1 604373 breast familial breast cancer AD no
PALB2 16p12.2 610355 Wilms tumour, medulloblastoma, AML, breast Fanconi anaemia N, breast cancer susceptibility AD no
RAD51C 17q22 602774 Breast,ovarian cancer Breast-ovarian cancer, familial, susceptibility to, 3 AD no
RAD51D 17q12 602954 Breast,ovarian cancer Breast-ovarian cancer, familial, susceptibility to, 4 AD no
Genes that have moderate or high risk based on published studies but pending professional recommendations regarding surveillance and risk reduction strategies
ATR 3q23 601215 oropharyngeal familial cutaneous telangiectasia and cancer syndrome, Seckel Syndrome AD no
AXIN2 17q24.1 604025 colorectal carcinoma oligodontia-colorectal cancer syndrome AD no
BARD1 2q35 601593 ovarian cancer, breast cancer, endometrioid cancer AD no
BLM 15q26.1 604610 leukaemia, lymphoma, skin squamous cell, other tumour types Bloom syndrome AD no
CDC73 1q31.2 607393 parathyroid adenoma, multiple ossifying jaw fibroma hyperparathyroidism-jaw tumour syndrome AD no
CDKN1B 12p13.1 600778 pituitary, parathyroid multiple endocrine neoplasia type IV AD no
DICER1 14q32.13 606241 pleuropulmonary blastoma familial pleuropulmonary blastoma or DICER1 syndrome AD no
EXT2 11p11.2 608210 exostoses, osteosarcoma multiple exostoses type 2 AD no
GALNT12 9q22.33 610290 colorectal Colorectal cancer, susceptibility to, 1 AD no
HNF1A 12q24.31 142410 hepatic adenoma, hepatocellular carcinoma familial hepatic adenoma AD no
HOXB13 17q21-q22 604607 prostate Prostate cancer, hereditary, 9 AD no
HRAS 11p15.5 190020 rhabdomyosarcoma, ganglioneuroblastoma, bladder Costello syndrome AD no
KDR 4q12 191306 melanoma Hemangioma, capillary infantile, susceptibility to AD no
KIT 4q12 164920 gastrointestinal, epithelioma familial gastrointestinal stromal tumour AD no
MAX 14q23.3 154950 pheochromocytoma Pheochromocytoma, susceptibility to AD no
MITF 3p13 156845 melanoma Melanoma, cutaneous malignant, susceptibility to, 8 AD no
PDGFRA 4q12 173490 gastrointestinal stromal tumour familial gastrointestinal stromal tumour AD no
PHB 17q21.33 176705 Breast cancer {Breast cancer, susceptibility to} AD no
PHOX2B 4p13 603851 neuroblastoma familial neuroblastoma AD no
POLD1 19q13.33 174761 colorectal Lynch syndrome AD no
PRF1 10q22.1 170280 various leukaemia, lymphoma AD no
PRKAR1A 17q24.2 188830 myxoma, endocrine, papillary thyroid Carney complex AD no
RAD50 5q31.1 604040 breast cancer Nijmegen breakage syndrome-like disorder AR no
RAD51A 15q15.1 179617 breast cancer ?Fanconi anemia, complementation group R AD no
RAD54L 1p34.1 603615 breast cancer Breast cancer, invasive ductal AD no
SDHA 5p15.33 600857 paraganglioma paragangliomas-5 (PGL5) AD no
SMARCB1 22q11.23 601607 malignant rhabdoid rhabdoid predisposition syndrome AD no
SMARCE1 17q21.2 603111 meningioma Meningioma, familial, susceptibility to AD no
TERT 5p15.33 187270 melanoma Melanoma, cutaneous malignant, 9 AD no
TMEM127 2q11.2 613403 pheochromocytoma, renal cell carcinoma Pheochromocytoma, susceptibility to AD no
DDB2 11p11.2 600811 skin basal cell, skin squamous cell, melanoma xeroderma pigmentosum (E) AR no
RECQL4 8q24.3 603780 osteosarcoma, skin basal cell, skin sqamous cell Rothmund-Thompson syndrome AR no
XPA 9q22.33 611153 skin basal cell, skin squamous cell, melanoma xeroderma pigmentosum (A) AR no
XPC 3p25.1 613208 skin basal cell, skin squamous cell, melanoma xeroderma pigmentosum (C) AR no
SUFU 10q24.32 607035 medulloblastoma medulloblastoma predisposition AR, AD no
GPC3 Xq26.2 300037 Wilms tumour Simpson-Golabi-Behmel syndrome XLR no
WAS Xp11.23 300392 lymphoma Wiskott-Aldrich syndrome XLR no